vs
亚什兰（ASH）与迈心诺（MASI）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是迈心诺的1.0倍（$386.0M vs $371.5M），亚什兰净利率更高（-3.1% vs -27.0%，领先23.9%），亚什兰同比增速更快（-4.7% vs -26.4%），亚什兰自由现金流更多（$111.0M vs $50.9M），过去两年迈心诺的营收复合增速更高（-17.7% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
迈心诺（Masimo Corporation）是总部位于美国加利福尼亚州尔湾的健康科技及消费电子企业，核心产品包括面向医院及家用场景的患者监护设备、无创传感器及配套软件平台，同时也布局了消费级音频和可穿戴设备赛道。
ASH vs MASI — 直观对比
营收规模更大
ASH
是对方的1.0倍
$371.5M
营收增速更快
ASH
高出21.7%
-26.4%
净利率更高
ASH
高出23.9%
-27.0%
自由现金流更多
ASH
多$60.1M
$50.9M
两年增速更快
MASI
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $371.5M |
| 净利润 | $-12.0M | $-100.4M |
| 毛利率 | 27.2% | 62.1% |
| 营业利润率 | -1.6% | 22.5% |
| 净利率 | -3.1% | -27.0% |
| 营收同比 | -4.7% | -26.4% |
| 净利润同比 | 92.7% | -1124.5% |
| 每股收益（稀释后） | $-0.26 | $-1.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHMASI
| Q4 25 | $386.0M | — | ||
| Q3 25 | $477.0M | $371.5M | ||
| Q2 25 | $463.0M | $370.9M | ||
| Q1 25 | $479.0M | $372.0M | ||
| Q4 24 | $405.0M | $600.7M | ||
| Q3 24 | $521.0M | $504.6M | ||
| Q2 24 | $544.0M | $496.3M | ||
| Q1 24 | $575.0M | $492.8M |
净利润ASHMASI
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $31.0M | $-100.4M | ||
| Q2 25 | $-742.0M | $51.3M | ||
| Q1 25 | $31.0M | $-170.7M | ||
| Q4 24 | $-165.0M | $-349.6M | ||
| Q3 24 | $17.0M | $9.8M | ||
| Q2 24 | $6.0M | $16.0M | ||
| Q1 24 | $120.0M | $18.9M |
毛利率ASHMASI
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | 62.1% | ||
| Q2 25 | 28.5% | 62.9% | ||
| Q1 25 | 30.7% | 62.9% | ||
| Q4 24 | 27.4% | 40.7% | ||
| Q3 24 | 33.2% | 52.2% | ||
| Q2 24 | 34.2% | 51.3% | ||
| Q1 24 | 28.0% | 49.0% |
营业利润率ASHMASI
| Q4 25 | -1.6% | — | ||
| Q3 25 | 12.8% | 22.5% | ||
| Q2 25 | -152.9% | 17.4% | ||
| Q1 25 | 10.6% | 21.0% | ||
| Q4 24 | -44.2% | -59.8% | ||
| Q3 24 | 6.1% | 6.0% | ||
| Q2 24 | -11.2% | 5.7% | ||
| Q1 24 | 3.7% | 6.9% |
净利率ASHMASI
| Q4 25 | -3.1% | — | ||
| Q3 25 | 6.5% | -27.0% | ||
| Q2 25 | -160.3% | 13.8% | ||
| Q1 25 | 6.5% | -45.9% | ||
| Q4 24 | -40.7% | -58.2% | ||
| Q3 24 | 3.3% | 1.9% | ||
| Q2 24 | 1.1% | 3.2% | ||
| Q1 24 | 20.9% | 3.8% |
每股收益（稀释后）ASHMASI
| Q4 25 | $-0.26 | — | ||
| Q3 25 | $0.83 | $-1.84 | ||
| Q2 25 | $-16.21 | $0.94 | ||
| Q1 25 | $0.65 | $-3.12 | ||
| Q4 24 | $-3.50 | $-6.54 | ||
| Q3 24 | $0.34 | $0.18 | ||
| Q2 24 | $0.12 | $0.29 | ||
| Q1 24 | $2.39 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $312.3M |
| 总债务越低越好 | $1.4B | $559.1M |
| 股东权益账面价值 | $1.9B | $810.0M |
| 总资产 | $4.5B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资ASHMASI
| Q4 25 | $304.0M | — | ||
| Q3 25 | $215.0M | $312.3M | ||
| Q2 25 | $207.0M | $149.6M | ||
| Q1 25 | $168.0M | $130.8M | ||
| Q4 24 | $219.0M | $177.6M | ||
| Q3 24 | $300.0M | $158.5M | ||
| Q2 24 | $399.0M | $129.6M | ||
| Q1 24 | $439.0M | $157.6M |
总债务ASHMASI
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $559.1M | ||
| Q2 25 | $1.4B | $613.7M | ||
| Q1 25 | $1.3B | $651.0M | ||
| Q4 24 | $1.3B | $765.2M | ||
| Q3 24 | $1.3B | $772.6M | ||
| Q2 24 | $1.3B | $781.6M | ||
| Q1 24 | $1.3B | $876.0M |
股东权益ASHMASI
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.9B | $810.0M | ||
| Q2 25 | $1.9B | $1.0B | ||
| Q1 25 | $2.6B | $946.4M | ||
| Q4 24 | $2.6B | $1.1B | ||
| Q3 24 | $2.9B | $1.5B | ||
| Q2 24 | $3.0B | $1.4B | ||
| Q1 24 | $3.1B | $1.4B |
总资产ASHMASI
| Q4 25 | $4.5B | — | ||
| Q3 25 | $4.6B | $1.8B | ||
| Q2 25 | $4.6B | $2.4B | ||
| Q1 25 | $5.2B | $2.3B | ||
| Q4 24 | $5.2B | $2.6B | ||
| Q3 24 | $5.6B | $3.1B | ||
| Q2 24 | $5.7B | $2.9B | ||
| Q1 24 | $5.9B | $3.0B |
负债/权益比ASHMASI
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | 0.69× | ||
| Q2 25 | 0.73× | 0.59× | ||
| Q1 25 | 0.52× | 0.69× | ||
| Q4 24 | 0.51× | 0.73× | ||
| Q3 24 | 0.47× | 0.53× | ||
| Q2 24 | 0.45× | 0.57× | ||
| Q1 24 | 0.42× | 0.64× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $56.8M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $50.9M |
| 自由现金流率自由现金流/营收 | 28.8% | 13.7% |
| 资本支出强度资本支出/营收 | 3.6% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | $191.0M |
8季度趋势，按日历期对齐
经营现金流ASHMASI
| Q4 25 | $125.0M | — | ||
| Q3 25 | $40.0M | $56.8M | ||
| Q2 25 | $115.0M | $69.4M | ||
| Q1 25 | $9.0M | $31.1M | ||
| Q4 24 | $-30.0M | $50.5M | ||
| Q3 24 | $80.0M | $25.6M | ||
| Q2 24 | $127.0M | $74.5M | ||
| Q1 24 | $54.0M | $45.8M |
自由现金流ASHMASI
| Q4 25 | $111.0M | — | ||
| Q3 25 | $6.0M | $50.9M | ||
| Q2 25 | $95.0M | $65.6M | ||
| Q1 25 | $-12.0M | $28.5M | ||
| Q4 24 | $-53.0M | $46.0M | ||
| Q3 24 | $42.0M | $16.9M | ||
| Q2 24 | $98.0M | $66.9M | ||
| Q1 24 | $20.0M | $37.6M |
自由现金流率ASHMASI
| Q4 25 | 28.8% | — | ||
| Q3 25 | 1.3% | 13.7% | ||
| Q2 25 | 20.5% | 17.7% | ||
| Q1 25 | -2.5% | 7.7% | ||
| Q4 24 | -13.1% | 7.7% | ||
| Q3 24 | 8.1% | 3.3% | ||
| Q2 24 | 18.0% | 13.5% | ||
| Q1 24 | 3.5% | 7.6% |
资本支出强度ASHMASI
| Q4 25 | 3.6% | — | ||
| Q3 25 | 7.1% | 1.6% | ||
| Q2 25 | 4.3% | 1.0% | ||
| Q1 25 | 4.4% | 0.7% | ||
| Q4 24 | 5.7% | 0.7% | ||
| Q3 24 | 7.3% | 1.7% | ||
| Q2 24 | 5.3% | 1.5% | ||
| Q1 24 | 5.9% | 1.7% |
现金转化率ASHMASI
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | 1.35× | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | 2.61× | ||
| Q2 24 | 21.17× | 4.66× | ||
| Q1 24 | 0.45× | 2.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
MASI
暂无分部数据
